Osimertinib for EGFR-mutant non-small cell lung cancer: place in therapy and future perspectives

by Ricciuti, Biagio
Published in J Thorac Dis (2019)

First line osimertinib for the treatment of patients with advanced EGFR-mutant NSCLC

by Ricciuti, Biagio, Chiari, Rita
Published in Transl Lung Cancer Res (2018)

Double aortic arch with right positioned descending thoracic aorta and coexistent aortic kinking

by Ricciuti, Biagio, Rebonato, Alberto, Capodicasa, Enrico
Published in BMJ Case Rep (2015)

Impact of performance status and age on osimertinib efficacy in patients with EGFR-mutant T790M-positive non-small-cell lung cancer

by Lamberti, Giuseppe, Andrini, Elisa, Ricciuti, Biagio
Published in J Thorac Dis (2019)

Melanosis coli or ischaemic colitis? That is the question

by Ricciuti, Biagio, Leone, Maria Comasia, Metro, Giulio
Published in BMJ Case Rep (2015)

Emerging Biomarkers in the Era of Personalized Cancer Medicine

by Ricciuti, Biagio, Leonardi, Giulia C., Brambilla, Marta
Published in Dis Markers (2019)

Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?

by Paglialunga, Luca, Salih, Zena, Ricciuti, Biagio, Califano, Raffaele
Published in ESMO Open (2016)

Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken opt...

by Ricciuti, Biagio, Lamberti, Giuseppe, Roila, Fausto, Metro, Giulio
Published in Transl Lung Cancer Res (2019)

Exclusion of patients living with HIV from cancer immune checkpoint inhibitor trials

by Vora, Kruti B., Ricciuti, Biagio, Awad, Mark M.
Published in Sci Rep (2021)

Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience

by Ricciuti, Biagio, Baglivo, Sara, De Giglio, Andrea, Chiari, Rita
Published in Ther Adv Respir Dis (2018)

Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: a short review on the current evidence

by Ricciuti, Biagio, Genova, Carlo, Crinò, Lucio, Libra, Massimo, Leonardi, Giulia Costanza
Published in Onco Targets Ther (2019)

Tumor Response Dynamics During First-Line Pembrolizumab Therapy in Patients With Advanced Non–Small-Cell Lung Cancer

by Nishino, Mizuki, Hong, Fangxin, Ricciuti, Biagio, Hatabu, Hiroto, Awad, Mark M.
Published in JCO Precis Oncol (2021)

Non-coding RNAs in lung cancer

by Ricciuti, Biagio, Mecca, Carmen, Crinò, Lucio, Baglivo, Sara, Cenci, Matteo, Metro, Giulio
Published in Oncoscience (2014)

Targeting EGFR and ALK in NSCLC: current evidence and future perspective

by Bennati, Chiara, Paglialunga, Luca, Ricciuti, Biagio, Metro, Giulio, Marcomigni, Luca, Gili, Alessio, Crinò, Lucio
Published in Lung Cancer Manag (2016)

Immune-related Adverse Events on Body CT in Patients with Small-Cell Lung Cancer Treated with Immune-checkpoint inhibitors

by Park, Hyesun, Hatabu, Hiroto, Ricciuti, Biagio, Aijazi, Safiya J., Awad, Mark M., Nishino, Mizuki
Published in Eur J Radiol (2020)

Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy

by Ricciuti, Biagio, Baglivo, Sara, Paglialunga, Luca, De Giglio, Andrea, Bellezza, Guido, Chiari, Rita, Crinò, Lucio, Metro, Giulio
Published in Ther Adv Med Oncol (2017)

Whole exome sequencing (WES) analysis of transformed small cell lung cancer (SCLC) from lung adenocarcinoma (LUAD)

by Xie, Tongji, Li, Yan, Ying, Jianming, Cai, Weijing, Li, Junling, Lee, Kye Young, Ricciuti, Biagio, Pacheco, Jose, Xing, Puyuan
Published in Transl Lung Cancer Res (2020)

Association between smoking history and tumor mutation burden in advanced non-small cell lung cancer

by Wang, Xinan, Ricciuti, Biagio, Nguyen, Tom, Li, Xihao, Rabin, Michael S., Awad, Mark M., Lin, Xihong, Johnson, Bruce E., Christiani, David C.
Published in Cancer Res (2021)

Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC)

by Ricciuti, Biagio, Jones, Greg, Severgnini, Mariano, Alessi, Joao V, Recondo, Gonzalo, Lawrence, Marissa, Forshew, Tim, Lydon, Christine, Nishino, Mizuki, Cheng, Michael, Awad, Mark
Published in J Immunother Cancer (2021)

Enteric-type adenocarcinoma of the lung harbouring a novel KRAS Q22K mutation with concomitant KRAS polysomy: a case report

by Metro, Giulio, Valtorta, Emanuele, Siggillino, Annamaria, Lauricella, Calogero, Cenci, Matteo, Ludovini, Vienna, Minenza, Elisa, Prosperi, Enrico, Ricciuti, Biagio, Rebonato, Alberto, Bassetti, Alessandra, Crinò, Lucio
Published in Ecancermedicalscience (2015)